A recent study reveals that people who discontinue popular weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who end conventional lifestyle programs.
Findings released in a leading health publication shows that while overweight individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month after stopping.
"Individuals using such treatments should be aware of the potential of fast weight regain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
That rate of regain suggests a return to starting weight in about a year and a half.
Weighing Treatments
The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists emphasize that people who shed pounds through dieting typically experience a slower creep back—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Doctors suggest the mode of action of the injections is key to understanding the accelerated weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this medication results in hunger is unsuppressed, making binge eating a significant risk."
A Chronic Condition?
The NHS advise the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Professionals say that, due to the high risk of relapse, the therapy might need to be life-long.
This opinion is supported by pharmaceutical companies, who say that the results "highlight the chronic character of excess weight," akin to managing diseases like diabetes.
Patient Accounts
People who have discontinued the medication describe a intense return of cravings.
"It felt as if a trigger flipping and I was suddenly starving," said one woman.
This difficulty is exacerbated if individuals have not developed sustainable lifestyle or habit modifications during therapy.
Significant Interest
Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is greater among women than males.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts caution that while the jabs are potent agents for shedding pounds, they are not a magic fix and lasting health benefits hinges on integrated behavioural support.
